Guardant Health Stock Target Price and Analyst Consensus

GH Stock  USD 42.89  2.25  5.54%   
The current analyst and expert consensus on Guardant Health is Strong Buy with 7 buy recommendations. The current projected Guardant Health target price consensus is 44.10, with 22 analyst opinions. Guardant Health buy-or-sell recommendation module provides average expert sentiment on the projected Guardant Health target price to derive its highest and lowest estimates based on target price estimated volatility of 5.2508. Check out Macroaxis Advice on Guardant Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Lowest Forecast
40.13
Highest Forecast
48.95
Target Price
44.1
The Guardant Health's current Gross Profit is estimated to increase to about 471.7 M, while Pretax Profit Margin is projected to decrease to (0.62). As of now, Guardant Health's Other Assets are increasing as compared to previous years. The Guardant Health's current Cash And Short Term Investments is estimated to increase to about 856.3 M, while Total Assets are projected to decrease to under 1.4 B.
  
It's important to approach Guardant Health's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Guardant Health Target Price Consensus

Guardant target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Guardant Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   22  Strong Buy
Most Guardant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Guardant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Guardant Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Guardant Health Target Price Projection

Guardant Health's current and average target prices are 42.89 and 44.10, respectively. The current price of Guardant Health is the price at which Guardant Health is currently trading. On the other hand, Guardant Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Guardant Health Market Quote on 15th of March 2025

Low Price41.01Odds
High Price43.09Odds

42.89

Target Price

Analyst Consensus On Guardant Health Target Price

Low Estimate40.13Odds
High Estimate48.95Odds

44.1

Historical Lowest Forecast  40.13 Target Price  44.1 Highest Forecast  48.95
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Guardant Health and the information provided on this page.

Guardant Health Analyst Ratings

Guardant Health's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Guardant Health stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Guardant Health's financials, market performance, and future outlook by experienced professionals. Guardant Health's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Guardant Health price targets

Guardant Health's stock target price is an estimate of its future price, usually made by analysts. Using Guardant Health's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Guardant Health's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Guardant Health's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Guardant Health Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Guardant Health is a key component of Guardant Health valuation and have some predictive power on the future returns of a Guardant Health.
Hype
Prediction
LowEstimatedHigh
38.0043.2548.50
Details
Intrinsic
Valuation
LowRealHigh
37.6142.8648.11
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.95-0.85-0.35
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Guardant Health. Your research has to be compared to or analyzed against Guardant Health's peers to derive any actionable benefits. When done correctly, Guardant Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Guardant Health.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 60 shares
Cash Cows Idea
Cash Cows
Invested few shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 40 shares
Apparel Idea
Apparel
Invested over 40 shares
Casinos Idea
Casinos
Sold over 90 shares
Basic Utilities Idea
Basic Utilities
Invested over 90 shares
Check out Macroaxis Advice on Guardant Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.